2020 SHBC | Agenda

February 27, 2020 | MIT Building E14

5:30-7:00pm:

VIP Reception (separate registration required)

7:00-9:00pm:

Sloan Healthcare Innovations Prize Pitch Competition Finals (free - must register separately for this event)

February 28, 2020 | MIT Building E14

8:00am: Networking breakfast

Continental breakfast provided to all attendees

8:55am: welcome remarks

Shouvik Das, MBA and MS 2020, MIT Sloan School of Management & MIT School of Engineering

Anthony Ndikum, MBA 2020, MIT Sloan School of Management

9:00am: Opening keynote

Michael S. Vincent, MD, PhD, Senior Vice President, Chief Scientific Officer of Inflammation and Immunology Research and Development, Pfizer

10:00AM: panel 1

Commercializing Personalized Therapies

Moderator:
- Tom Murtagh, Founder & Managing Director, Clarion Healthcare
Panelists:
- Fanny Cavalie, VP of Business Development and Operations, Foghorn Therapeutics
- Cecilia Fernández, PhD, Genome Editing Strategy and Operations Leader
- Jerry Keybl, PhD, Head of Cell & Gene Therapy Manufacturing, MilliporeSigma
- Andrea Conley, Head of Operations, Patient and Product Services, Sanofi Genzyme

11:00AM: panel 2

Designing Patient-centric Data Systems

Moderator:
- Jonathan Fleming, General Partner, Oxford Bioscience Partners
Panelists:
- Brian Cantwell, Senior Director & Head of US Multichannel Excellence, Biogen
- Gino Korolev, VP of Solutions, Onduo
- Alex Waldron, CSO, Pear Therapeutics
- Amy Wilson, SVP of Clinical Operations, Ascension
- Marcus Leef, VP of Business Development and Innovation, Optum

12:00pm: networking lunch

Catered lunch provided to all attendees

1:00pm: fireside chat

Moderator: Jonathan Fleming, General Partner, Oxford Bioscience Partners

Noubar Afeyan, PhD, Founder & CEO, Flagship Pioneering

Mark Trusheim, MSc, Strategic Director, MIT New Drug Development Paradigms (NEWDIGS)

2:00pm: innovation roadshow

Sloan Healthcare Innovations Prize (SHIP) 2020 Winners

Aetion: Powering critical decisions in healthcare with data science-driven technology

nQ Medical: Data-driven solutions for neurodegenerative diseases

Root Health: Enabling personalized healthcare research

InfiniteMD: using technology to connect patients to the world’s brightest healthcare experts enabling more personalized care

3:00pm: panel 3

Defining Personalized Medicine in Emerging Markets

Moderator:
- Vik Bakhru, MD, COO, ConsejoSano and Founder & Chairman of the Board, Foundation for International Medical Relief of Children
Panelists:
- Kristian Olson, MD, Director of the Consortium for Affordable Medical Technologies, Massachusetts General Hospital
- Ian Woo, President & CFO, Everest Medicines
- Karla Unger, Research Professor, National Cancer Institute
- Anjali Sastry, PhD, Senior Lecturer, System Dynamics, MIT Sloan School of Management